PAVmed (PAVM) Preferred Shares Issued (2017 - 2024)
PAVmed's quarterly Preferred Shares Issued came in at $11.6 million in Q2 2024, down 35.96% quarter-over-quarter from $18.2 million in Q1 2024.
PAVmed has reported Preferred Shares Issued for 3 years, with the latest figure at $11.6 million in Q2 2024.
- For the quarter ending Q2 2024, Preferred Shares Issued changed N/A year-over-year to $11.6 million; the trailing twelve-month figure through Dec 2024 stood at $34.8 million (up 86.83% YoY), and the FY2024 full-year result was $29.8 million, up 59.99% from the prior year.
- Preferred Shares Issued for Q2 2024 stood at $11.6 million, down from $18.2 million in the prior quarter.
- The five-year high for Preferred Shares Issued was $18.2 million in Q1 2024, with the low at $5.0 million in Q4 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Preferred Shares Issued (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | - |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | - |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2024 | 11.63 Mn |
| Jun 30, 2024 | 11.63 Mn |
| Mar 31, 2024 | 18.17 Mn |
| Mar 31, 2024 | 18.17 Mn |
| Dec 31, 2023 | 5.00 Mn |
| Dec 31, 2023 | 5.00 Mn |
| Mar 31, 2023 | 13.63 Mn |
| Mar 31, 2023 | 13.63 Mn |
| Jun 30, 2017 | 37,012.00 |
| Jun 30, 2017 | 37,012.00 |
| Mar 31, 2017 | 2.54 Mn |
| Mar 31, 2017 | 2.54 Mn |